Primary information |
---|
CancerPDF_ID | CancerPDF_ID12691 |
PMID | 25168216 |
Peptide Sequence | RALAFR |
Peptide Sequence in Publication | RALAFR |
Protein Name | NA |
UniprotKB Entry Name | NA |
Biofluid | Serum |
M/Z | NA |
Charge | NA |
Mass/H+ | NA |
Mass (in Daltons) | 732.44 |
Profiling Technique | LC-MS |
Peptide Identification Technique | LC-MS/MS |
Quantification Technique | NA |
Labeling | Label Free |
FDR | NA |
p-Value | 2.69E_05 |
Software | MASCOT |
Length of Peptide | 6 |
Cancer Type | Renal cell carcinaoma |
Database for Peptide search | SwissProt Database |
Modification | |
Number of Patients | "30 RCC patients and 30 healthy controls for training dataset and 6 RCC patients, 6 control in independent validation dataset" |
Regulation/Differential Expression | Upregulated in cancer v/s Normal |
Validation | Independent validation |
Sensitivity | 100 % (for 19 peptide signatures) |
Specificity | NA |
Accuracy | AUC : 0.853 |
Secondary information |
---|
Peptide Atlas | |
IEDB | |